This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The battle over prescription drug discounts offered to hospitals under a federal program escalated as Sanofi became the third pharmaceuticalcompany to disclose plans to change the way it will make payments. Right now, drug companies generally provide the discounts at the time of purchase.
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.
For several years , some of the world’s largest pharmaceuticalcompanies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.
Federal lawmakers investigating the Steward Health Care bankruptcy moved on Thursday to compel testimony from chief executive Ralph de la Torre about his role in the hospital system’s financial collapse.
Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceuticalcompany Regeneron has invested $119.5
The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceuticalcompany has spent on marketing to doctors since such data became available in 2017.
Pharmaceuticalcompanies have long been driven by global demand and the potential for the highest profits. The move could act as a proof of concept for bringing drugs to UK patients that pharmaceuticalcompanies aren’t willing to risk their profits on. That fact can hardly be contested.
In a setback to the pharmaceutical industry, a U.S. appeals court has upheld an Arkansas law that allows hospitals participating in a controversial federal discount program to ship medicines to certain pharmacies. There are roughly 12,400 hospitals and clinics that participate across the U.S.
Novartis has filed a lawsuit seeking to block a Maryland law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial U.S. government drug discount program. Continue to STAT+ to read the full story…
In a bid to blunt competition and address rising drug costs, Sanofi is offering a warranty that will cover the cost for any hospital if a specific medicine fails to work, marking only the second time a major pharmaceuticalcompany has taken such a step.
government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceuticalcompany has been threatened with such a step. Continue to STAT+ to read the full story…
The heads of pharmaceuticalcompanies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls. Those figures compared to an average of $13 million and median of $4.3 million in 2022. Continue to STAT+ to read the full story…
Rising drug costs are putting increasing pressure on healthcare systems, highlighting the need for rational and responsible medicines use, according to a new study looking at cost-effective and sustainable drug use in hospitals. Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach. 2024 Dec 19.
Tero Silvola is CEO and board member of BC Platforms, and owner of Riverpark Oy, an investment and development company co-operating with five IT and healthcare start-ups. Emanuel Timor, general partner, Vertex Ventures has more than 20 years of experience working with start-up companies and emerging businesses.
Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceuticalcompanies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceuticalcompanies and patient and caregivers.”.
AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial federal discount program. The move comes less than a month after a U.S. The move comes less than a month after a U.S.
RwHealth , the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceuticalcompanies.
The Janssen PharmaceuticalCompanies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).
Better management of customer data could help pharmaceuticalcompanies’ digital transformation, according to Veeva’s Rebecca Silver. She pointed to the Veeva European Customer Reference Data Survey that showed 41% of companies are not satisfied with the quality of their third-party legacy providers of customer data.
Sensyne Health has signed a five-year non-exclusive Strategic Research Agreement (SRA) with Milton Keynes University Hospital NHS Foundation Trust (MKUH). MKUH will take an equity stake in Sensyne Health and receive 1,428,571 ordinary shares in the UK company, representing 1.1% The dataset covers 650,000 unique patient records.
Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceuticalcompanies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. . Dr Hughes earned his MD and PhD at Yale School of Medicine.
It also allows pharmaceuticalcompanies to monitor product information and keep it constantly updated, as well as offering healthcare professionals and patients greater accessibility. Pharmaceuticalcompanies participating in the pilot create and submit the ePI via the PLM Portal as part of their regulatory application.
The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceuticalcompanies, medical device firms, and numerous other entities occur almost weekly.
A company being built from the ashes of IBM’s Watson Health division is launching new lines of business with a much different message: The real value is in the health data, not the fancy AI engine it might eventually power. Continue to STAT+ to read the full story…
[pharmaceuticalcompanies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.
But this could only be made financially viable if community pharmacies were given the same discounts on these drugs that NHS trusts do, and therefore a three-way agreement between hospital, community pharmacy and pharmaceuticalcompanies would need to be in place.
Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 2006: Congress passed, and President George W.
The massive sum spent by the company, which makes the blockbuster Humira anti-inflammatory drug, is the most a pharmaceuticalcompany has doled out on marketing to doctors since such data became available in 2017. Continue to STAT+ to read the full story…
In the same statement, Pfizer also announced it has signed a pledge by the US Department of Health and Human Services (HHS) that calls on US healthcare system stakeholders such as hospitals, health systems, payers, suppliers and pharmaceuticalcompanies to reduce GHG emissions and build a more climate resilient healthcare infrastructure.
In Portugal, students visit numerous community pharmacies, a pharmaceuticalcompany, a clinical laboratory, an oncology hospital and a cooperative wholesaling company.
With COVID-19 anticipated to change how pharmaceuticalcompanies engage with healthcare professionals, Ipsen UK&I is preparing for a more remote and virtual healthcare system. Prior to the pandemic, 95% of all the company’s UK customer facing teams’ interactions took place in person at NHS hospitals.
Multinational drug and medical device makers are grappling with narrower profit margins in China, largely due to the country’s system of having companies bid to supply drugs and devices to public hospitals — known as volume-based procurement. Continue to STAT+ to read the full story…
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
Pharmaceuticalcompanies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. In 2014 Keith was fortunate to become a full-time salaried patient research ambassador at Liverpool Heart and Chest Hospital Trust.
17 Clinical validation and standardising dosing Collaboration among pharmaceuticalcompanies, regulatory bodies and healthcare providers is essential for developing standardised frameworks for precision dosing. appeared first on Hospital Pharmacy Europe. J Natl Cancer Inst 2018;110(10):116672.
VMLY&Rx, a comms agency dedicated to prescription pharmaceuticalcompanies who are researching and developing breakthrough therapies, has hired Nichole Davies as global chief strategy officer. . Davies will lead a new global strategic practice to deliver and enable connected health strategies for clients.
Numerous pharmaceuticalcompanies are diversifying their portfolios, while some are taking a leap into the ATMP (Advanced Therapy Medicinal Product) era. Over the decades, the pharmaceutical industry, as well as the regulators, have embraced changes at its fastest pace. The combination of the two above.
In addition to the recent reimbursement cuts, a host of harmful actions by pharmaceutical manufacturers are causing issues. Hospitals and clinics are eligible based on defined criteria. The Centers for Medicare and Medicaid Services (CMS) continues to provide reduced payments to 340B hospitals. So, how does 340B ESP work?
The Italian pharmaceuticalcompany Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings.
Though pharmaceutical firms and medical device makers have cleaned up their acts, regulatory hasn’t really let up. This is a risky strategy because it leaves companies open to ethics violations of the broader universe of agents and distributors.
Fresenius Kabi is a global healthcare company specialising in medicines and technologies for infusion, transfusion and clinical nutrition. Hospital clinicians should never have to decide whether our +RFID products are compatible; medications should work effortlessly in whatever system a hospital wants to purchase.
The 340B Drug Pricing Program enables safety-net providers—select hospitals, clinics, and health centers that serve a disproportionate share of poor patients in these urban and rural areas—to buy prescription drugs at discounted prices. It’s worth noting that, while these hospitals represent about 5 percent of all U.S.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content